Methyl 2H-indazole-7-carboxylate
CAS : 952479-65-1
Ref. 3D-CNB47965
| 1g | Arrêté | ||
| 5g | Arrêté | ||
| 100mg | Arrêté | ||
| 250mg | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
Methyl 2H-indazole-7-carboxylate
Description :
Methyl 2H-indazole-7-carboxylate is a synthetic compound that has been identified as a potential treatment for cancer. It is an inhibitor of the enzyme glutathione reductase, which is involved in maintaining the balance between oxidants and antioxidants in cells. Methyl 2H-indazole-7-carboxylate has been shown to induce apoptosis in human leukemia cells by inhibiting glutathione reductase and thereby increasing the levels of reactive oxygen species (ROS) within the cell. Methyl 2H-indazole-7-carboxylate was shown to have anti-inflammatory properties in a study where it inhibited prostaglandin synthesis by blocking cyclooxygenases (COX).
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
176.17 g/mol
Formule :
C9H8N2O2
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
